Table 1.

Laboratory findings on presentation

Complete blood count		Biochemistiy		Serology			CSF analysis
WBC	7,000	/µL	TP	6.7	g/dL	CRP	0.21	mg/dL	Opening pressure	18	mmH20
Neu	69.5	%	Alb	3.8	g/dL	ACE	5.0	U/L	Cells	94	/µL
Eo	0.4	%	AST	10	U/L	sIL2R	432	U/mL	Glu	4	mg/dL
Mo	7.2	%	ALT	10	U/L	Adenosine deaminase	29.2	IU/mL	Protein	1078	mg/dL
Ly	22.6	%	ALP	77	U/L	T-SPOT	(–)		ACE	5.4	U/L
RBC	409 × 104	/µL	γ-GTP	19	U/L	TSH	1.47	µIU/mL	sIL2R	6777	U/mL
Hb	13.4	g/dL	T.Bil	1.2	mg/dL	Free T4	1.22	pg/mL	Lysozyme	16.5	pg/mL
Hct	38.3	%	CPK	20	U/L	ANA	640	Fold	Adenosine deaminase	19.5	IU/mL
Pit	409 × 104	/µL	BUN	20.6	mg/dL	Anti-ds-DNA-Ab	<10	IU/mL	Culture for bacterium	(–)
			Cre	0.57	mg/dL	Anti-CCP-Ab	<0.5	U/mL	Culture and PCR for mycobacteria	(–)
Coagulation		UA		mg/dL	PR3-ANCA	<0.5	U/mL	PCR for herpes simplex virus	(–)
APTT	35.9	s	Na	131.3	mEq/L	MPO-ANCA	<0.5	EU	PCR for varicella-zoster virus	(–)
PT	92	%	K	3.8	mEq/L	C3	116	mg/dL	PCR for cytomegalovirus	(–)
PT-INR	1.0		Cl	93	mEq/L	C4	26.2	mg/dL	Ciyptococcus neoformans antigen	(–)
FDP	<2.5	µg/mL	Ca	9.3	mg/dL	CH50	51	U/mL	Aspergillus antigen	(–)
D-dimer	0.8	µg/mL	Glu	122	mg/dL	Anti-TPO-Ab	<9.0	IU/mL	Cytology class II
			HbA1c	5.4	%	Anti-Tg-Ab	1146	IU/mL	Oligoclonal band	(+)
						β-D glucan	<5.0	pg/mL	IgG index	1.6
						Anti-HIV Ab	(–)		Paraneoplastic antibodies panel*(–)

^*Paraneoplastic antibodies panel included Amphiphysin, CV2, PNMA2 (Ma2/Ta), Ri, Yo, Hu, recoverin, SOX1, titin, zic4, GAD65, and Tr(DNER).